Novel Therapies of Salivary Gland Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 10 April 2025 | Viewed by 164
Special Issue Editor
Interests: cancer research; salivary gland carcinoma
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Salivary gland cancer presents significant challenges due to its diverse histological subtypes; variable clinical behavior; and, like other head-and neck cancer subtypes, limited treatment options. Despite advancements in surgery, radiation therapy, and chemotherapy, the prognosis for patients with advanced or recurrent disease remains poor, highlighting the urgent need for novel therapeutic approaches.
Advances in molecular biology, immunology, and targeted therapies enable new therapeutic goals. These novel approaches aim to improve outcomes by enhancing tumor specificity, minimizing systemic toxicity, and overcoming treatment resistance. Additionally, a deeper understanding of the molecular pathways involved in salivary gland tumorigenesis has provided new opportunities for targeted intervention, paving the way for personalized treatment approaches tailored to the unique characteristics of individual tumors.
This Special Issue aims to support publishing manuscripts which provide emerging therapies for salivary gland cancer, encompassing both conventional modalities and cutting-edge advancements in the field. By elucidating the current landscape of therapeutic options and highlighting promising avenues for future research, this Special Issue seeks to contribute to the ongoing efforts made to improve outcomes and quality of life for patients with salivary gland cancer.
Dr. Moritz Meyer
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- salivary gland cancer
- treatment
- targeted therapy
- surgery
- radiation therapy
- survival
- life quality
- immunotherapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.